A61K2039/542 - page 2 - CPC Classification Index

#301

20180169198

2018-06-21

Compositions and methods of enhancing immune responses to or limiting infection

#302

20180169003

2018-06-21

Methods for delivering entanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

#303

20180161283

2018-06-14

Methods and products for treating and/or delaying onset of dysplastic lesions

#304

20180153981

2018-06-07

Composition for inducing proliferation or accumulation of regulatory T cells

#305

20180153980

2018-06-07

Inactivated Bacterial Cell Formulation

#306

20180153976

2018-06-07

NOVEL CMV PP65 TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY

#307

20180140701

2018-05-24

Stable aqueous formulations of adalimumab

#308

20180133300

2018-05-17

Vaccine composition for treating or preventing shigellosis

#309

20180125967

2018-05-10

HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto

#310

20180111964

2018-04-26

Fusion polypeptide for immuno-enhancement and method for enhancing stimulation of immune response using the same

#311

20180099043

2018-04-12

Methods to improve induction of IgA antibodies by vaccines

#312

20180071387

2018-03-15

IMMUNOMODULATORY COMPOSITIONS COMPRISING A POLYMER MATRIX AND AN OIL PHASE

#313

20180064794

2018-03-08

MSLN targeting DNA vaccine for cancer immunotherapy

#314

20180055930

2018-03-01

Stable aqueous formulations of adalimumab

#315

20180055929

2018-03-01

Stable aqueous formulations of adalimumab

#316

20180050099

2018-02-22

Personalized Site-Specific Immunomodulation

#317

20180043023

2018-02-15

DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS

#318

20180043019

2018-02-15

Stable aqueous formulations of adalimumab

#319

20180043018

2018-02-15

Stable aqueous formulations of adalimumab

#320

20180042816

2018-02-15

Manufacture of peanut formulations for oral desensitization

#321

20180037643

2018-02-08

Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

#322

20180028657

2018-02-01

Stable Aqueous Formulations of Adalimumab

#323

20180028656

2018-02-01

Stable Aqueous Formulations of Adalimumab

#324

20180028655

2018-02-01

Stable Aqueous Formulations of Adalimumab

#325

20180028654

2018-02-01

Methods of manufacturing stable aqueous formulations of adalimumab

#326

20180028653

2018-02-01

Syringe containing stable aqueous formulations of adalimumab

#327

20180021433

2018-01-25

Stable aqueous formulations of adalimumab

#328

20180002675

2018-01-04

Human ebola virus species and compositions and methods thereof

#329

20170368156

2017-12-28

Attenuated bacteria and methods of using

#330

20170367970

2017-12-28

Allergen dosage form

#331

20170342150

2017-11-30

METHOD OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES

#332

20170327830

2017-11-16

ATTENUATED LIVE BACTERIA WITH INCREASED ACID RESISTANCE AND METHODS OF USE THEREOF

#333

20170312361

2017-11-02

Stable aqueous formulations of adalimumab

#334

20170305974

2017-10-26

AGENT FOR CONTROLLING PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME

#335

20170296659

2017-10-19

Combination therapies

#336

20170281760

2017-10-05

Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota

#337

20170281755

2017-10-05

Oral administration of at least one pharmaceutical and/or antigenic active substance

#338

20170281545

2017-10-05

Immunomodulation using spores and pollen grains

#339

20170266272

2017-09-21

Transgenic Vero-CD4/CCR5 cell line

#340

20170260256

2017-09-14

Modified colostrum protein and application thereof

#341

20170246438

2017-08-31

Active agent delivery devices and methods of using the same

#342

20170246283

2017-08-31

Composition for inducing proliferation or accumulation of regulatory T cells

#343

20170231902

2017-08-17

Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

#344

20170224812

2017-08-10

Liquid immunity induction-promoting composition and vaccine pharmaceutical composition that include thrombosis treatment drug

#345

20170224801

2017-08-10

NANOPARTICLES FOR TREATMENT OF ALLERGY

#346

20170216429

2017-08-03

Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition

#347

20170181975

2017-06-29

Composition and method for reducing zoonotic infectious diseases

#348

20170174758

2017-06-22

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

#349

20170174735

2017-06-22

Compositions and methods relating to the treatment of diseases

#350

20170173147

2017-06-22

MICROPARTICULATED VACCINES FOR THE ORAL OR NASAL VACCINATION AND BOOSTERING OF ANIMALS INCLUDING FISH

#351

20170165357

2017-06-15

Immunotherapy composition and use thereof

#352

20170157244

2017-06-08

Vaccination response for immunodeficiency disorders or high cortisol

#353

20170157242

2017-06-08

Synergistic nutritional compositions and uses thereof

#354

20170151326

2017-06-01

Immunity inducer

#355

20170151325

2017-06-01

Compositions for delivery of food allergens to the stomach

#356

20170143823

2017-05-25

Mucosal adjuvants and delivery systems

#357

20170143775

2017-05-25

Compositions comprising bacterial strains

#358

20170142967

2017-05-25

Tannin-chitosan composites

#359

20170135958

2017-05-18

Use of vitelline protein B as a microencapsulating additive

#360

20170121402

2017-05-04

ORAL COMPOSITION OF ANTI-TNF ALPHA ANTIBODIES

#361

20170112925

2017-04-27

Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors

#362

20170112921

2017-04-27

Mixed allergen compositions and methods for using the same

#363

20170112920

2017-04-27

Mixed allergen compositions and methods for using the same

#364

20170112919

2017-04-27

Mixed allergen compositions and methods for using the same

#365

20170106069

2017-04-20

Soft gel delivery system for treating poultry

#366

20170106068

2017-04-20

ORAL COMPOSITION AND METHODS FOR IMMUNOTHERAPY

#367

20170100475

2017-04-13

Induction of mucosal tolerance to antigens

#368

20170100329

2017-04-13

Method and system for preventing migraine headaches, cluster headaches and dizziness

#369

20170095551

2017-04-06

Replication-competent VSV-HIV Env vaccines

#370

20170087231

2017-03-30

ALLERGEN FOR PROPHYLACTIC TREATMENT OF ALLERGY

#371

20170087197

2017-03-30

Composition for inducing proliferation or accumulation of regulatory T cells

#372

20170081399

2017-03-23

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

#373

20170080074

2017-03-23

Compositions produced using enteric pathogens and methods of use

#374

20170080073

2017-03-23

Compositions produced using enteric pathogens and methods of use

#375

20170080072

2017-03-23

Compositions produced using enteric pathogens and methods of use

#376

20170072054

2017-03-16

Stable aqueous formulations of adalimumab

#377

20170072033

2017-03-16

LIPOSOMAL COMPOSITIONS FOR MUCOSAL DELIVERY

#378

20170071867

2017-03-16

Nanoparticle compositions

#379

20170066841

2017-03-09

PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

#380

20170066824

2017-03-09

ANTI-INTERLEUKIN ANTIBODY PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

#381

20170056497

2017-03-02

Method of treating protozoal gastrointestinal disorders in immunocompromised patients

#382

20170056494

2017-03-02

Mixed allergen compositions and methods for using the same

#383

20170056491

2017-03-02

Adenoviral vector-based vaccine against enterovirus infection

#384

20170043013

2017-02-16

Compositions for antigen-specific induction of tolerance

#385

20170035872

2017-02-09

Compositions produced using enteric pathogens and methods of use

#386

20170028061

2017-02-02

Compositions and methods for induction of TH17 cells

#387

20170028054

2017-02-02

VACCINE COMPOSITION

#388

20170028046

2017-02-02

Vaccine against colibacillosis

#389

20170021012

2017-01-26

Peanut formulations and uses thereof

#390

20170021003

2017-01-26

Vaccination using plant virus particles linked to HER2 antigens

#391

20170020962

2017-01-26

Interleukin-2 for treating food allergy

#392

20170014350

2017-01-19

Oral virus vaccine

#393

20170008957

2017-01-12

ANTIBODY THERAPEUTICS WITH LOCAL ACTIVITY IN THE DIGESTIVE TRACT

#394

20170007683

2017-01-12

Tolerogenic compositions comprising and uses thereof

#395

20170002069

2017-01-05

Polypeptides

#396

20170000872

2017-01-05

Inactivated bacterial cell formulation

#397

20160367654

2016-12-22

Immunogenic compositions comprising

#398

20160367631

2016-12-22

C1q as a therapeutic agent of allergy and/or asthma

#399

20160354462

2016-12-08

Vaccine and therapeutic delivery system

#400

20160346373

2016-12-01

Algal based edible vaccines

#401

20160324962

2016-11-10

COMPOSITIONS AND METHODS FOR TREATING SARCOMA

#402

20160324767

2016-11-10

Allergen dosage form

#403

20160319039

2016-11-03

Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM

#404

20160317634

2016-11-03

NOVEL MSLN TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY

#405

20160304601

2016-10-20

Stable aqueous formulations of adalimumab

#406

20160304600

2016-10-20

Stable aqueous formulations of adalimumab

#407

20160304599

2016-10-20

Stable aqueous formulations of adalimumab

#408

20160303235

2016-10-20

Stable aqueous formulations of adalimumab

#409

20160303234

2016-10-20

Stable aqueous formulations of adalimumab

#410

20160303233

2016-10-20

Stable aqueous formulations of adalimumab

#411

20160303208

2016-10-20

Method for treating amyloid disease

#412

20160296469

2016-10-13

Composition for oral delivery of bioactive agents

#413

20160287698

2016-10-06

Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants

#414

20160280799

2016-09-29

Pulmonary administration of immunoglobulin single variable domains and constructs thereof

#415

20160271242

2016-09-22

Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides

#416

20160263226

2016-09-15

Stable aqueous formulations of adalimumab

#417

20160263212

2016-09-15

COMPOSITIONS AND METHODS FOR TOLERIZING THE IMMUNE SYSTEM TO ALLERGENS

#418

20160263211

2016-09-15

Stimulation of neonatal immunity against EHV-1

#419

20160256547

2016-09-08

Stable aqueous formulations of adalimumab

#420

20160256546

2016-09-08

Stable aqueous formulations of adalimumab

#421

20160256545

2016-09-08

Stable aqueous formulations of adalimumab

#422

20160250311

2016-09-01

DNA VACCINE FOR USE IN PANCREATIC CANCER PATIENTS

#423

20160243217

2016-08-25

Mixed allergen compositions and methods for using the same

#424

20160228539

2016-08-11

Toothpaste for delivery of allergens to oral mucosa

#425

20160228521

2016-08-11

MANAGING IMMUNE RESPONSES IN TRANSPLANTATION

#426

20160222393

2016-08-04

Live bacterial vectors for prophylaxis or treatment

#427

20160213773

2016-07-28

Mucosal vaccine composition

#428

20160213770

2016-07-28

Methods of using presenting N-glycan or derivatives thereof

#429

20160184425

2016-06-30

Efficient mucosal vaccination mediated by the neonatal Fc receptor

#430

20160175429

2016-06-23

Immunotherapy composition and use thereof

#431

20160136268

2016-05-19

Mammalian milk osteopontin for enhancing immune responsiveness

#432

20160113881

2016-04-28

Nanoparticle compositions

#433

20160101168

2016-04-14

Attenuated bacteria and methods of using

#434

20160089429

2016-03-31

Oral vaccine having improved cellular immunity induction potency

#435

20160089427

2016-03-31

Genetically modified as vaccines against species

#436

20160051661

2016-02-25

Fluorocarbon-linked peptide formulation

#437

20160045585

2016-02-18

Formulations

#438

20160039926

2016-02-11

Stable aqueous formulations of adalimumab

#439

20160032018

2016-02-04

Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa

#440

20160031982

2016-02-04

Stable aqueous formulations of adalimumab

#441

20160030289

2016-02-04

MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION

#442

20160015825

2016-01-21

Mucosal membrane receptor and uses thereof

#443

20160008459

2016-01-14

Immunogenic polypeptide surface layer-expressing bifidobacterium

#444

20160000895

2016-01-07

Compositions and methods of enhancing immune responses to or limiting infection

#445

20150328309

2015-11-19

Dose selection of adjuvanted synthetic nanocarriers

#446

20150320850

2015-11-12

Vaccine for protection against ETEC-induced diarrhea comprising dmLT

#447

20150313964

2015-11-05

Methods of reducing in poultry

#448

20150297705

2015-10-22

Preparation of live vaccines

#449

20150297703

2015-10-22

Bifidobacterium for dust mite allergy

#450

20150273050

2015-10-01

Formulations for non-invasive delivery of active proteins to an animal or human

#451

20150250832

2015-09-10

Bacterial composition for the treatment of colibacillosis on farms, in particular poultry farms, and also drinking water containing such a bacterial composition

#452

20150238591

2015-08-27

Multifunctional oral vaccine based on chromosome recombineering

#453

20150231228

2015-08-20

HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto

#454

20150218525

2015-08-06

Human Ebola virus species and compositions and methods thereof

#455

20150209410

2015-07-30

Compositions and methods relating to the treatment of diseases involving TH1 and TH2/TH17

#456

20150202275

2015-07-23

Plague vaccine

#457

20150191539

2015-07-09

Stable aqueous formulations of adalimumab

#458

20150191538

2015-07-09

Stable aqueous formulations of adalimumab

#459

20150190513

2015-07-09

Stable aqueous formulations of adalimumab

#460

20150190512

2015-07-09

Stable aqueous formulations of adalimumab

#461

20150190500

2015-07-09

Vaccine vectors and methods of enhancing immune responses

#462

20150182626

2015-07-02

Stable aqueous formulations of adalimumab

#463

20150182619

2015-07-02

Methods of vaccine administration

#464

20150175540

2015-06-25

Isoindolin-1-ones as macrophage migration inhibitory factor (MIF) inhibitors

#465

20150174229

2015-06-25

Inactivated mycobacteria for oral use in the prevention of tuberculosis

#466

20150165011

2015-06-18

DNA vaccine for use in pancreatic cancer patients

#467

20150150956

2015-06-04

EPITOPE COMPOSITION

#468

20150118319

2015-04-30

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

#469

20150118261

2015-04-30

vaccine combination

#470

20150094371

2015-04-02

Solid pharmaceutical compositions containing pregabalin

#471

20150079117

2015-03-19

Paramyxovirus immunogens and related materials and methods

#472

20150064197

2015-03-05

Methods of modulating immunity

#473

20150044243

2015-02-12

Mucosal immunization to prevent prion infection

#474

20150037370

2015-02-05

Diatom-based vaccines

#475

20150023962

2015-01-22

Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

#476

20140370057

2014-12-18

Attenuated live bacteria with increased acid resistance and methods of use thereof

#477

20140370041

2014-12-18

Compositions and methods for treating influenza

#478

20140348935

2014-11-27

Treatment of food intolerance and food allergy with IgM

#479

20140341947

2014-11-20

Immunogenic compositions comprising

#480

20140328873

2014-11-06

Norovirus immunogens and related materials and methods

#481

20140322297

2014-10-30

Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

#482

20140322266

2014-10-30

Induction of mucosal tolerance to antigens

#483

20140322230

2014-10-30

Induction of mucosal tolerance to antigens

#484

20140322201

2014-10-30

METHODS OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES

#485

20140314858

2014-10-23

IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same

#486

20140302089

2014-10-09

Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

#487

20140286986

2014-09-25

Polypeptides having immunoactivating activity and methods of producing the same

#488

20140271836

2014-09-18

Manufacture of peanut formulations for oral desensitization

#489

20140271722

2014-09-18

Allergen dosage form

#490

20140271721

2014-09-18

Peanut formulations and uses thereof

#491

20140243430

2014-08-28

Orally bioavailable lipid-based constructs

#492

20140242112

2014-08-28

NOVEL VACCINE

#493

20140234230

2014-08-21

Stomatological composition

#494

20140220661

2014-08-07

Live bacterial vaccines for prophylaxis or treatment of infection

#495

20140220079

2014-08-07

VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION

#496

20140220059

2014-08-07

WT1 peptide cancer vaccine composition for mucosal administration

#497

20140205625

2014-07-24

Methods to increase antigenicity of membrane-bound polypeptides produced in plants

#498

20140141031

2014-05-22

Pathogenic bacteria

#499

20140134238

2014-05-15

Tannin-chitosan composites

#500

20140112951

2014-04-24

Vaccine and drug delivery by intranasal application of vector and vector extracts

#501

20140105961

2014-04-17

Immunomodulation using spores and pollen grains

#502

20140093541

2014-04-03

Treatment for peanut allergy

#503

20140079795

2014-03-20

Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance

#504

20140017313

2014-01-16

Formulations

#505

20140004144

2014-01-02

Attenuated vaccines and methods of making and use thereof

#506

20130330374

2013-12-12

Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus

#507

20130302374

2013-11-14

Methods and compositions for dosing of allergens

#508

20130302372

2013-11-14

Vaccine for protection against

#509

20130295127

2013-11-07

Vaccine against

#510

20130295126

2013-11-07

Vaccines for inclusion body hepatitis

#511

20130273090

2013-10-17

Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use

#512

20130266612

2013-10-10

Vaccine composition

#513

20130216589

2013-08-22

ORAL VACCINE FOR AQUATIC ANIMALS

#514

20130202655

2013-08-08

Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration

#515

20130177593

2013-07-11

Personalized site-specific immunomodulation

#516

20130177550

2013-07-11

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

#517

20130171247

2013-07-04

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

#518

20130164331

2013-06-27

Oral vaccination of fish with live attenuated vaccines

#519

20130164264

2013-06-27

Method of preventing or treating influenza A viral infection using cloned DI influenza A viral particles

#520

20130136744

2013-05-30

Pulmonary administration of immunoglobulin single variable domains and constructs thereof

#521

20130129768

2013-05-23

Treatment or prevention of infection

#522

20130129762

2013-05-23

Marker vaccine for classical swine fever

#523

20130095134

2013-04-18

Stabilized virus like particles having enhanced mucosal immunogenicity

#524

20130095133

2013-04-18

Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof

#525

20130071434

2013-03-21

Campylobacter polypeptides and methods of use

#526

20130064854

2013-03-14

METHODS OF TREATING ALLERGIES WITH SUBSTANTIALLY PHENOL-FREE CARRIERS

#527

20130058969

2013-03-07

Chloroplasts engineered to express pharmaceutical proteins

#528

20130045228

2013-02-21

Vaccine for protection against

#529

20130034541

2013-02-07

PHARMACEUTICAL COMPOSITIONS

#530

20130022630

2013-01-24

Method for treating amyloid disease

#531

20130017220

2013-01-17

Gel vaccine delivery system for treating poultry

#532

20130011439

2013-01-10

Inactivated bacterial cell formulation

#533

20130004561

2013-01-03

Therapies for preventing or suppressing infection

#534

20130004547

2013-01-03

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS

#535

20120321655

2012-12-20

LENTIVIRUS VACCINE BASED ON THE RECOMBINANT VIRAL VACCINE AGAINST YELLOW FEVER

#536

20120301494

2012-11-29

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

#537

20120288552

2012-11-15

Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

#538

20120288523

2012-11-15

ADMINISTRATION ROUTE FOR A COMPOSITION TO PROTECT AN ANIMAL AGAINST RHODOCOCCUS EQUI

#539

20120282291

2012-11-08

Vaccine vectors and methods of enhancing immune responses

#540

20120276167

2012-11-01

IMMUNOPROTECTION BY ORAL ADMINISTRATION OF RECOMBINANT LACTOCOCCUS LACTIS MINI-CAPSULES

#541

20120269846

2012-10-25

Adjuvanted rabies vaccine with improved viscosity profile

#542

20120258145

2012-10-11

Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof

#543

20120258135

2012-10-11

Immunogenic anti-inflammatory compositions

#544

20120258118

2012-10-11

ANTIBODY THERAPEUTICS WITH LOCAL ACTIVITY IN THE DIGESTIVE TRACT

#545

20120251502

2012-10-04

Human Ebola Virus Species and Compositions and Methods Thereof

#546

20120244600

2012-09-27

Swine influenza hemagglutinin variants

#547

20120244185

2012-09-27

IMMUNIZATION STRATEGY TO PREVENT H1N1 INFECTION

#548

20120237547

2012-09-20

Live attenuated rotavirus vaccine for oral administration

#549

20120237544

2012-09-20

Bacterial spore having therapeutic agent adsorbed on its surface

#550

20120232149

2012-09-13

SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN

#551

20120225091

2012-09-06

Modified live (JMSO strain) vaccine

#552

20120213828

2012-08-23

Adenovirus vaccine vector and methods of use

#553

20120213780

2012-08-23

Efficient mucosal vaccination mediated by the neonatal Fc receptor

#554

20120183572

2012-07-19

Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition

#555

20120183570

2012-07-19

Antigen compositions and methods of inhibiting bacterial infection and uses of the antigen compositions

#556

20120177687

2012-07-12

Gene expressing a bifidobacterium surface-presented fusion protein

#557

20120177682

2012-07-12

system and uses thereof

#558

20120174264

2012-07-05

Uses of Yerba Santa

#559

20120171230

2012-07-05

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM

#560

20120171198

2012-07-05

Use of IgGimmunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route

#561

20120156287

2012-06-21

Use of vitelline protein B as a microencapsulating additive

#562

20120156240

2012-06-21

Methods for preparing vesicles and formulations produced therefrom

#563

20120148570

2012-06-14

METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE-CHALLENGED ANIMALS

#564

20120142080

2012-06-07

Live bacterial vaccines for viral infection prophylaxis or treatment

#565

20120141585

2012-06-07

Immunomodulatory compositions comprising a polymer matrix and an oil phase

#566

20120135039

2012-05-31

Oral Vaccines for Producing Mucosal Immunity

#567

20120135038

2012-05-31

EXPRESSION OF PROTECTIVE ANTIGENS IN TRANSGENIC CHLOROPLASTS AND THE PRODUCTION OF IMPROVED VACCINES

#568

20120121645

2012-05-17

SUPRALINGUAL VACCINES AND APPLICATORS

#569

20120121620

2012-05-17

ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER

#570

20120115161

2012-05-10

COMPOSITIONS AND METHODS FOR DEMONSTRATING SECRETORY IMMUNE SYSTEM REGULATION OF STEROID HORMONE RESPONSIVE CANCER CELL GROWTH

#571

20120114693

2012-05-10

NUCLEIC ACID MUCOSAL IMMUNIZATION

#572

20120100177

2012-04-26

presenting N-glycan or derivatives thereof

#573

20120100165

2012-04-26

Drug transporter, and adjuvant and vaccine each utilizing same

#574

20120100163

2012-04-26

SUPPRESSION OF A TYPE 1 HYPERSENSITIVITY IMMUNE RESPONSE WITH AN UNRELATED ANTIGEN

#575

20120093871

2012-04-19

Modified protozoan expressing at least two variable surface proteins (VSP), a vaccine comprising it and procedures, uses, and methods thereof

#576

20120087944

2012-04-12

Oral vaccine fast-dissolving dosage form using starch

#577

20120082648

2012-04-05

Colonization factor (CF) antigens of enterotoxigenic escherichia coli in recombinant bacteria

#578

20120076824

2012-03-29

E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines

#579

20120070453

2012-03-22

Methods for preparing and delivering adjuvant compositions

#580

20120064169

2012-03-15

Multiple antigen delivery system using hepatitis E virus-like particle

#581

20120040010

2012-02-16

Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish

#582

20120039956

2012-02-16

Dry storage stabilizing composition for biological materials

#583

20120039931

2012-02-16

DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof

#584

20120034305

2012-02-09

SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY

#585

20120034206

2012-02-09

BREAST CANCER ERADICATION PROGRAM

#586

20120029081

2012-02-02

Solid Pharmaceutical Compositions Containing Pregabalin

#587

20120028258

2012-02-02

Receptor gene screening for detecting or diagnosing cancer

#588

20120027836

2012-02-02

E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines

#589

20120027806

2012-02-02

Dose selection of adjuvanted synthetic nanocarriers

#590

20120003269

2012-01-05

Compositions Produced Using Enteric Pathogens and Methods of Use

#591

20110318384

2011-12-29

Stable constitutively high expression vector for preparing HPV vaccine and recombinant lactic acid bacteria transformed thereby

#592

20110318379

2011-12-29

Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic

#593

20110311617

2011-12-22

Oral vaccine

#594

20110305768

2011-12-15

QUICK-DISSOLVING ORAL THIN FILM FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

#595

20110305753

2011-12-15

Treatment of celiac disease with IgA

#596

20110293723

2011-12-01

SYNTHETIC NANOCARRIER COMBINATION VACCINES

#597

20110293701

2011-12-01

MULTIVALENT SYNTHETIC NANOCARRIER VACCINES

#598

20110293700

2011-12-01

NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT

#599

20110293659

2011-12-01

Method for the oral/mucosal vaccination by means of recombinant yeasts

#600

20110293657

2011-12-01

Encapsulated vaccines for the oral vaccination and boostering of fish and other animals